Silencing of miR‑155 suppresses inflammatory responses in psoriasis through inflammasome NLRP3 regulation
- PMID: 29767259
- DOI: 10.3892/ijmm.2018.3677
Silencing of miR‑155 suppresses inflammatory responses in psoriasis through inflammasome NLRP3 regulation
Abstract
Psoriasis is a dermatosis with the major clinical symptoms of scale, erythema and itching, and it has a long disease course. In addition, it is easily recurrent and refractory, greatly affecting the physical and mental health of patients. In the present study, it was hypothesized that the function of miR‑155 increases psoriasis‑induced inflammation and that its expression may be dependent on inflammasome activation. miR‑155 expression was examined by gene chip array and quantitative polymerase chain reaction analysis. miR‑155 expression levels were significantly increased in an in vivo model of psoriasis compared with normal tissues, as was the expression of NLR family pyrin domain containing 3 (NLRP3). In vitro, using keratinocyte‑induced HaCaT cells as a model for psoriasis, silencing of miR‑155 was confirmed to significantly decrease inflammation and NLRP3/caspase‑1 signaling. Activation of toll‑like receptor 4 (TLR4) enhanced the miR‑155‑induced inflammatory response in the in vitro keratinocyte model. Treatment with a TLR4 inhibitor or an NLRP3 inhibitor reversed the miR‑155‑mediated inflammation in the same cell system. The present study demonstrated that miR‑155 silencing suppressed psoriasis‑associated inflammatory responses through inflammasome NLRP3 regulation.
Similar articles
-
MicroRNA‑33 regulates the NLRP3 inflammasome signaling pathway in macrophages.Mol Med Rep. 2018 Feb;17(2):3318-3327. doi: 10.3892/mmr.2017.8224. Epub 2017 Dec 8. Mol Med Rep. 2018. PMID: 29257274
-
NLRP3 inflammasome inactivation driven by miR‑223‑3p reduces tumor growth and increases anticancer immunity in breast cancer.Mol Med Rep. 2019 Mar;19(3):2180-2188. doi: 10.3892/mmr.2019.9889. Epub 2019 Jan 23. Mol Med Rep. 2019. PMID: 30747211 Free PMC article.
-
Human parvovirus B19 nonstructural protein NS1 activates NLRP3 inflammasome signaling in adult‑onset Still's disease.Mol Med Rep. 2018 Feb;17(2):3364-3371. doi: 10.3892/mmr.2017.8275. Epub 2017 Dec 12. Mol Med Rep. 2018. PMID: 29257322
-
Regulation and Function of the Nucleotide Binding Domain Leucine-Rich Repeat-Containing Receptor, Pyrin Domain-Containing-3 Inflammasome in Lung Disease.Am J Respir Cell Mol Biol. 2016 Feb;54(2):151-60. doi: 10.1165/rcmb.2015-0231TR. Am J Respir Cell Mol Biol. 2016. PMID: 26418144 Free PMC article. Review.
-
The role of NLRP3 inflammasome in infection-related, immune-mediated and autoimmune skin diseases.J Dermatol Sci. 2020 Jun;98(3):146-151. doi: 10.1016/j.jdermsci.2020.03.001. Epub 2020 Mar 6. J Dermatol Sci. 2020. PMID: 32173167 Review.
Cited by
-
Is Mir-205 a possible biomarker for evaluating treatment response in psoriasis?J Med Life. 2024 Mar;17(3):353-359. doi: 10.25122/jml-2024-0264. J Med Life. 2024. PMID: 39044928 Free PMC article.
-
Purinergic Signaling and Inflammasome Activation in Psoriasis Pathogenesis.Int J Mol Sci. 2021 Aug 31;22(17):9449. doi: 10.3390/ijms22179449. Int J Mol Sci. 2021. PMID: 34502368 Free PMC article. Review.
-
Acetylsalicylic Acid Suppresses Alcoholism-Induced Cognitive Impairment Associated with Atorvastatin Intake by Targeting Cerebral miRNA155 and NLRP3: In Vivo, and In Silico Study.Pharmaceutics. 2022 Feb 27;14(3):529. doi: 10.3390/pharmaceutics14030529. Pharmaceutics. 2022. PMID: 35335908 Free PMC article.
-
Construction of a lncRNA-miRNA-mRNA network to determine the regulatory roles of lncRNAs in psoriasis.Exp Ther Med. 2019 Nov;18(5):4011-4021. doi: 10.3892/etm.2019.8035. Epub 2019 Sep 23. Exp Ther Med. 2019. PMID: 31611939 Free PMC article.
-
The role of miRNAs in Behçet's disease.Front Immunol. 2023 Oct 4;14:1249826. doi: 10.3389/fimmu.2023.1249826. eCollection 2023. Front Immunol. 2023. PMID: 37860009 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical